Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: Money Maker (MM) who wrote (59627)	3/4/1999 10:54:00 AM
From: cyberman	Read Replies (2) \| Respond to of 119973

EPAY gaining some momentum towards analyst recommendations and price targets - also CKFR having problems?

To: Money Maker (MM) who wrote (59627)	3/4/1999 10:56:00 AM
From: Tomstocks	Respond to of 119973

CELN: Celsion Delivers BPH Treatment System for Development of a Non-Invasive Temperature Monitoring Device March 4, 1999 09:00 AM COLUMBIA, Md.--(BW HealthWire)--March 4, 1999-- -- Department of Health and Human Services Funds Project with $455,000 Grant -- Celsion Corp. CELN today announced that it delivered its patented benign prostatic hyperplasia (BPH) treatment system to MMTC, Inc. of Princeton, NJ for use in the development of a second generation system. The project is being funded by a $455,000 Small Business Innovation Research (SBIR) Phase II grant from the Department of Health and Human Services (DHHS). Research conducted under the grant is expected to create the optimum protocol and design for a non-invasive temperature sensing device to monitor prostate temperatures. The device will be incorporated into Celsion's second generation BPH system to provide enhanced real-time prostate temperature data, a desirable feature which is absent in all other BPH thermotherapy systems on the market. After work performed at MMTC, the system will be transported to the Montefiore Medical Center in Bronx, NY where animal tests will be performed under the DHHS research grant. MEASURING TEMPERATURE WITH MICROWAVE RADIOMETRY CELN Chairman and Chief Scientific Officer Dr. Augustine Cheung said, "Our goal in enhancing the BPH system is to offer a safe, effective, non-surgical treatment providing immediate relief and long-term symptom control of the urinary obstruction condition often caused by BPH, an enlargement of the prostate gland which afflicts roughly 50% of men over 55. "The availability of a real-time, non-invasive temperature measurement device would further enhance the safety and efficacy of our BPH system by monitoring the temperature of the treated area to avoid overheating," Cheung added. "By enabling the documentation of treatment dose and efficacy data, the system should allow physicians to create a data bank in order to prescribe individually tailored treatments." The temperature sensing device under development for inclusion in Celsion's second generation BPH system incorporates a novel measurement principle based on microwave radiometry. Celsion's existing system offers a dual modality approach for non-surgical management and treatment of BPH, incorporating both balloon dilation and heat therapy. Preclinical studies in animals of the current first generation system indicated that this unique approach should be capable of providing immediate symptomatic relief and long-term symptom control. BPH CLINICALS UNDERWAY AT MONTEFIORE MEDICAL CENTER Clinical evaluations of the first generation system, which has an Investigational Device Exemption (IDE) from the Food and Drug Administration (FDA), are underway at the Montefiore Medical Center in Bronx, NY to demonstrate clinical efficacy in humans. Once the clinicals are completed, Celsion intends to bring its BPH treatment system to market abroad and apply for FDA Premarket Approval (PMA) for commercialization in the U.S. "Our current BPH system is positioned to notably expand the $9 billion worldwide market for BPH treatment by encouraging more men to seek treatment, especially those with moderate symptoms," stated CELN President and CEO Spencer Volk. "We expect the current clinical studies to confirm the 'walk-in be treated, walk-out with total relief' nature of our out-patient BPH system. Once the accuracy of the new temperature sensing device is verified in animals, we will include that capability in our BPH treatment system." ABOUT CELSION In addition to its BPH treatment system, under an FDA IDE Celsion is preparing to conduct clinicals of its breast cancer treatment system to demonstrate that focused heat alone safely and effectively ablates tumors. Celsion's research is concentrated on designing focused heat systems to treat additional cancers. Celsion Corporation is a research and development company dedicated to commercializing medical treatment systems for cancer and BPH using focused heat delivered by patented microwave technology. Clinicals and further development of the Company's treatment systems are being conducted by leading institutions such as the Massachusetts Institute of Technology, Massachusetts General Hospital, Montefiore Medical Center, and Duke University. Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, possible changes in cost of materials, expense items, capital expenditures, capital structure, and other financial items; introduction of new products and possible acquisitions of assets or businesses; possible actions by customers, suppliers, competitors, regulatory authorities; and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.

To: Money Maker (MM) who wrote (59627)	3/4/1999 11:23:00 AM
From: ArtAlley	Read Replies (1) \| Respond to of 119973

ASCT: anyone know what is going on? Two large block sales of over 20,000 jumped price up over $1.25 per share in a couple of minutes...back down a little now.

To: Money Maker (MM) who wrote (59627)	3/4/1999 12:14:00 PM
From: Nescom	Respond to of 119973

RMAG 1.3 mil float and news out today. RMAG is engaged in the development and marketing of applications software incorporating core speech recognition technology. RMAG products are designed to enable a user to perform tasks or retrieve information by speaking into a telephone or computer. For the three months ended 10/31/98, revenues totalled $282 thousand, up from $113 thousand. Net loss totalled $1.1 million, up from $316 thousand. Results reflect the addition of computer software sales, offset by higher personnel costs. PR: Registry Magic Joins AT&T, Lucent and Motorola to Standardize Voice Access to the Internet tagged for: LHSPF DLGC NTL INTL RMAG T LU MOT NIPNY retrieval keys: !business !hightech !infotech !public+companies !wall+street adoption banking biz business commerce computer computers corporate finance insurance internet manufacturing market nasdaq newsgrid nyase nyse otc platinum products property securities sports technology trade traffic usa weather world+wide+web BOCA RATON, FLA. (March 4) BUSINESS WIRE -March 4, 1999-- Open Standard Can Allow Companies To Extend Their Internet Reach to Anyone in the World With a Voice and Telephone Registry Magic(R) (Nasdaq:RMAG) announced it has joined with AT&T (NYSE:T), Lucent Technologies (NYSE:LU), and Motorola (NYSE:MOT) in the formation of the Voice eXtensible Markup Language Forum (VXML Forum) to make the resources of the World Wide Web accessible to anyone by speaking into a telephone. The Forum aims to drive the market for voice- and phone-enabled Internet access by promoting a standard specification for VXML, a computer language used to create Web content and services. "The VXML initiative is a powerful step in establishing an industry standard in which Registry Magic can provide companies with products and services to expand their Internet reach to anyone in the world with a voice and telephone, not just those in front of a PC or with PC skills. Registry Magic is excited to join forces with these industry leaders to standardize voice access to the Internet." said Walt Nawrocki, CEO and President of Registry Magic. Examples of VXML uses include allowing a salesperson to dial into a corporate intranet from any phone and using conversational interaction to receive real-time order status information. Similarly, users could access Web-based weather, sports or traffic information, banking transaction services, and other electronic commerce applications without touching a computer keyboard. "Just as standardization of HTML (Hypertext Markup Language) drove the adoption of traditional Web applications, standardization of VXML will drive the adoption of voice-enabled applications," said Maria Martinez, vice president and general manager, Internet and Connectivity Solutions Division (ICSD), Motorola, Inc. "We are pleased to have Registry Magic join us in this initiative." Named a 'National Treasure' by the Smithsonian Institution, Registry Magic's Virtual Operator(R) technology performs the tasks of a live employee using conversational speech recognition technology. The recipient of many industry awards, the Virtual Operator is in use by both small and Fortune 500 size companies alike in industries including finance, insurance, manufacturing, distribution, automotive and call centers. Internationally, where touch-tone technology may not be prevalent, the Virtual Operator technology can provide telephone automation where not available by other means. For additional information on the VXML forum, visit the web site at www.vxmlforum.org. Registry Magic is a leader in conversational speech recognition technologies, products and services. The company's award-winning products utilize proprietary technologies from Registry Magic and Lernout & Hauspie (Nasdaq:LHSPF) and understand spoken words making it easy to access data and perform human-like tasks. Registry Magic is a Dialogic (Nasdaq:DLGC) Platinum Partner and a member of the Nortel Networks (NYSE:NTL)Business Affiliate Program, the Siemens Ready Program, and the NEC (Nasdaq:NIPNY) Fusion Program. Authorized dealers and distributors include among others, Entex Information Systems, Inter-Tel (Nasdaq:INTL), and Teleco. For more information on Registry Magic products and services, please call 888/762-4428 or visit the Web site at www.registrymagic.com. All trademarks or registered trade names are property of their respective holders. Except for the historical information contained herein, the matters discussed in this news release are forward-looking statements. Readers are cautioned that such forward-looking statements involve risk and uncertainties including without limitation the general risks associated with the intense competition and rapid technological change characteristic of the computer telephony and speech technology markets. The forward-looking statements contained herein speak only as of the date of this release and are subject to risks set forth in Registry Magic's reports filed with the Securities and Exchange Commission. Registry Magic expressly disclaims any obligations or undertaking to publicly release any updates or revisions to any such statement to reflect any change in expectations or any change in events, conditions or circumstances on which any such statement is based. -0- APS/se* CONTACT: L & L Communications Media Relations Lisa Buyer-Atkinson, 954/426-5127 lisa@llcomm.com OR Investor Relations Frank Hawkins, 305/852-2383 fhawk@hawkassociates.com OR Sales/Product Information Donna Marvin, 561/367-0408 donna.marvin@registrymagic.com KEYWORD: FLORIDA INDUSTRY KEYWORD: INTERACTIVE/MULTIMEDIA/INTERNET COMED COMPUTERS/ELECTRONICS TELECOMMUNICATIONS Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page.